Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $664.03 billion, total revenue of $165.59 billion and a weighted average PE ratio of 37.77.
Market Cap
664.03B
Revenue
165.59B
Profits
17.58B
PE Ratio
37.77
Profit Margin
10.62%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 182.57B | -0.62% | 1,696,260 | 44.56B |
| 2 | DHR | Danaher Corporation | 135.26B | 0.17% | 2,739,684 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.35B | 0.87% | 734,217 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.63B | 0.82% | 1,111,902 | 7.07B |
| 5 | WAT | Waters Corporation | 29.85B | 1.45% | 727,267 | 3.17B |
| 6 | NTRA | Natera, Inc. | 29.48B | 2.35% | 1,279,465 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 29.08B | 0.50% | 794,277 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.51B | -1.11% | 87,734 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 22.55B | 0.36% | 467,247 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.76B | 0.17% | 519,962 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 19.48B | 0.59% | 960,279 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 14.14B | 1.81% | 284,308 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 12.31B | 2.94% | 1,743,916 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.94B | 1.16% | 949,752 | 2.86B |
| 15 | ICLR | ICON Public Limited Company | 8.72B | 2.49% | 661,099 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.56B | -0.58% | 839,180 | 4.02B |
| 17 | QGEN | Qiagen N.V. | 8.46B | 1.61% | 1,276,363 | 2.09B |
| 18 | SHC | Sotera Health Company | 4.25B | 0.61% | 3,960,850 | 1.16B |
| 19 | RDNT | RadNet, Inc. | 4.25B | -0.94% | 997,872 | 2.04B |
| 20 | BLLN | BillionToOne, Inc. | 3.65B | -4.34% | 362,571 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 3.08B | 1.35% | 970,546 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.56B | -0.46% | 702,899 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.26B | 2.59% | 792,247 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.94B | 1.04% | 338,519 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 1.04B | 3.23% | 1,794,518 | 727.33M |
| 26 | CDNA | CareDx, Inc. | 937.77M | 2.46% | 341,855 | 379.81M |
| 27 | OPK | OPKO Health, Inc. | 865.34M | 0.88% | 1,156,050 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 738.52M | -0.84% | 288,512 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 688.48M | 0.30% | 977,333 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 485.17M | 2.31% | 556,224 | 322.67M |
| 31 | MYGN | Myriad Genetics, Inc. | 444.16M | 3.49% | 1,147,745 | 824.50M |
| 32 | PRE | Prenetics Global Limited | 331.18M | 0.56% | 116,443 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 174.42M | -0.61% | 55,935 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 148.57M | 2.10% | 41,828 | 88.50M |
| 35 | FONR | FONAR Corporation | 121.87M | 0.05% | 10,298 | 106.03M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 120.95M | 9.30% | 296,093 | 4.06M |
| 37 | MDXH | MDxHealth SA | 110.95M | -3.13% | 215,717 | 107.88M |
| 38 | XGN | Exagen Inc. | 73.60M | 1.66% | 105,602 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 45.31M | 3.31% | 40,070 | 24.05M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 17.62M | -1.51% | 1,444,982 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 13.26M | 1.11% | 215,714 | - |
| 42 | NOTV | Inotiv, Inc. | 9.18M | 2.42% | 155,366 | 514.03M |
| 43 | ADVB | Advanced Biomed Inc. | 6.21M | 2.02% | 2,938 | - |
| 44 | XWEL | XWELL, Inc. | 6.17M | -7.76% | 182,439 | 29.21M |
| 45 | QUCY | Mainz Biomed N.V. | 5.73M | -3.96% | 24,986 | 1.07M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.47M | -1.29% | 11,039 | - |
| 47 | ISPC | iSpecimen Inc. | 1.39M | -6.45% | 1,785,532 | 1.93M |